JPMorgan analyst Alexei Gogolev downgraded SS&C to Neutral from Overweight with a price target of $86, down from $90. Following the Q1 report, the firm has less conviction that SS&C can reliably grow through pricing and volume organically, as opposed to its “tried-and- true strategy” of acquisitions. JPMorgan no longer has conviction that the company’s mid-term organic growth target of “high single digit” at the upper end of the range is going to materialize, which it believes “dampens the attractiveness” of the investment case.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SSNC:
- SS&C Technologies Holdings: Strong Financial Performance and Growth Potential Highlighted by Buy Rating
- SS&C Technologies Reports Strong Q1 2025 Earnings
- Closing Bell Movers: Alphabet up 5% after earnings beat
- SS&C reports Q1 adjusted EPS $1.44, consensus $1.41
- SS&C sees Q2 adjusted EPS $1.35-$1.41, consensus $1.42